 |
|
|
|
January 2001 Cover
|
|
The Food and Drug Administration has granted Bristol-Myers Squibb permission to sell a new once-a-day formula of its HIV treatment Videx that causes fewer adverse events, such as diarrhea. According to
Bristol-Myers, Videx EC is the only HIV treatment currently available in a once-daily formula.
Providing simple HIV dosing schedules has become increasingly important, as patients are required to take several drugs at different times of the day and non-compliance can result in increased drug resistance.
Editor's Note: from Reuters
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
